These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12772053)

  • 21. Postinfectious irritable bowel syndrome.
    DuPont AW
    Clin Infect Dis; 2008 Feb; 46(4):594-9. PubMed ID: 18205536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatments targeting putative mechanisms in irritable bowel syndrome.
    Cremonini F; Talley NJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):82-8. PubMed ID: 16265125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogenesis of irritable bowel syndrome: current understanding].
    Basilisco G
    Recenti Prog Med; 2007 Nov; 98(11):543-7. PubMed ID: 18044402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: therapeutic roles of acupuncture in functional gastrointestinal disorders.
    Ouyang H; Chen JD
    Aliment Pharmacol Ther; 2004 Oct; 20(8):831-41. PubMed ID: 15479354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irritable bowel syndrome and bloating.
    Hasler WL
    Best Pract Res Clin Gastroenterol; 2007; 21(4):689-707. PubMed ID: 17643909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spectrum of irritable bowel syndrome: A clinical review.
    Gilkin RJ
    Clin Ther; 2005 Nov; 27(11):1696-709. PubMed ID: 16368443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current views of the pathogenesis of irritable bowel syndrome].
    Zhukov NA; Sorokina EA; Akhmedov VA; Trem'iakova TV
    Klin Med (Mosk); 2003; 81(12):7-13. PubMed ID: 14971149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychotherapy in somatic diseases--for example gastrointestinal disorders].
    Moser G
    Psychiatr Danub; 2007 Dec; 19(4):327-31. PubMed ID: 18000484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
    Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
    Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome.
    Ohman L; Simrén M
    Dig Liver Dis; 2007 Mar; 39(3):201-15. PubMed ID: 17267314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Humoral factors (beta-endorphin and adrenocorticotropin) in irritable bowel syndrome and their relations with psychological disorders and characteristics of disorders in the large intestine motility].
    Zhukov NA; Sorokina EA; Kazakova AV; Akhmedov VA; Tuleeva NK; Tret'iakova TV; Sen'ko MV
    Eksp Klin Gastroenterol; 2003; (6):46-51, 154. PubMed ID: 15065528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychosomatic motility disorders of the upper gastrointestinal tract and the possibility of their psychotherapeutic influence.
    Lukásová A; Cerný M; Kazil P; Srnec J; Setka O; Vrba V
    Act Nerv Super (Praha); 1973 Mar; 15(1):57. PubMed ID: 4698113
    [No Abstract]   [Full Text] [Related]  

  • 33. The pathophysiology of irritable bowel syndrome.
    Schwetz I; Bradesi S; Mayer EA
    Minerva Med; 2004 Oct; 95(5):419-26. PubMed ID: 15467517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypnosis for functional abdominal pain.
    Gottsegen D
    Am J Clin Hypn; 2011 Jul; 54(1):56-69. PubMed ID: 21922712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Visceral sensitivity disturbances in the pathogenesis of functional gastrointestinal disorders].
    Mazur M; Furgała A; Thor PJ
    Folia Med Cracov; 2004; 45(1-2):33-49. PubMed ID: 16276824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypnosis helps irritable bowel syndrome. For IBS, beneficial effects of hypnotherapy may last for up to five years.
    Health News; 2004 Jan; 10(1):9. PubMed ID: 15002382
    [No Abstract]   [Full Text] [Related]  

  • 37. [A method for non-medicamentous treatment of irritated bowel syndrome].
    Sobin DIu; Korepanov AM
    Vopr Kurortol Fizioter Lech Fiz Kult; 2009; (3):19-22. PubMed ID: 19639692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered protease signalling in the gut: a novel pathophysiological factor in irritable bowel syndrome.
    Róka R; Wittmann T; Bueno L
    Neurogastroenterol Motil; 2008 Aug; 20(8):853-6. PubMed ID: 18710475
    [No Abstract]   [Full Text] [Related]  

  • 39. [Irritable bowel syndrome: issues of diagnosis and treatment efficiency].
    Loranskaia ID
    Eksp Klin Gastroenterol; 2008; (1):90-5. PubMed ID: 19145859
    [No Abstract]   [Full Text] [Related]  

  • 40. The brain-gut axis in irritable bowel syndrome--clinical aspects.
    Mach T
    Med Sci Monit; 2004 Jun; 10(6):RA125-31. PubMed ID: 15173682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.